Posted on

Low Carb Diet Boosts Weight Loss for Liver Transplant Recipients With Obesity

Loading

— LCD also positively impacted patients’ metabophenotype

Liver transplant recipients benefited from a low carbohydrate diet (LCD), achieving weight loss and an improved metabolic phenotype profile, according to a randomized trial.

In an interim analysis involving 27 patients, those who followed an LCD had a significantly higher mean weight loss of nearly 8 kg (about 17 lbs) over 6 months, compared to those on a low calorie restricted diet (CRD), who did not experience any significant weight loss (P=0.01), reported Mohammad Siddiqui, DO, of Virginia Commonwealth University in Richmond. Read more in MedPage Today.

Loading
Posted on

The Importance of Transplant Nephrology to a Successful Kidney Transplant Program

Loading

Introduction

Nephrologists are responsible for the care of patients with a diverse array of systemic diseases, comorbidities, and kidney issues across a variety of service locations (clinic, inpatient, dialysis unit). As the field of nephrology becomes increasingly complex, there has been a need for advanced training and subspecialization, similar to the transformation cardiology experienced with heart failure, electrophysiology, and interventional cardiology. Read the full article in the Clinical Journal of the American Society of Nephrology (CJASN).

Loading
Posted on

New modeling system identifies potential therapeutics for autosomal recessive polycystic kidney disease

Loading

Organoids-;lab grown cells or tissues that resemble organs-;serve as a new tool for disease modeling, but researchers often have difficulty replicating the biophysical conditions in which the organs operate within the body.

This is especially true for modeling human diseases that require stimuli from cell microenvironments. Read more in News Medical Life Sciences.

Loading
Posted on

Did My Strong COVID Vax Reaction Give Me Better Immunity?

Loading

— As people roll up their sleeves for another booster, here’s where the science stands

Is a strong reaction to the COVID-19 vaccine a sign of a more robust immune response that ultimately brings better protection against infection, hospitalization, and death?

Many are asking that question as they roll up their sleeves for yet another booster.

Science doesn’t have a definitive answer, as the literature is generally mixed — although two papers in the JAMA network of journals suggest that experiencing more side effects does correlate with higher levels of anti-spike antibodies. Read more in MedPage Today.

Loading
Posted on

First pig-to-human cardiac transplant alters heart’s electrical signals

Loading

A recent study to be presented at the American Heart Association (AHA) Scientific Sessions 2022* revealed unexpected changes in the electrical conduction system of the first genetically-modified porcine-to-human heart xenotransplant.

Xenotransplantation is the procedure of transplantation/implantation into a human of organs from non-human animal sources. Read more in News Medical Life Sciences.

Loading
Posted on

Religiosity and spirituality may positively impact the well-being of kidney transplant recipients

Loading

1. In this scoping review, religiosity and spirituality (R/S) were positively associated with the well-being of kidney transplant recipients, primarily through increased adherence to immunosuppressant medication and coping.

2. Locus of control had a significant impact on adherence to immunosuppressive medications post-kidney transplantation.

Read more in 2 minute medicine.

Loading
Posted on

Nevada Donor Network closer to opening statewide transplant institute

Loading

Since 2019, the Nevada Donor Network Foundation has been on a mission to bring a new transplant institute to Nevada. 

And due to a recent investment of American Rescue Plan Act funds, the nonprofit has gotten closer to bringing the institute to life. 

But why a new transplant institute? Especially since there is already a center for transplantation at University Medical Center. To answer that is Joe Ferreira, the CEO and president of the Nevada Donor Network. Check out the full story from Nevada Public Radio.

Loading
Posted on

CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week

Loading

NOVEMBER, 02, 2022

CareDx Showcases Latest Innovations in Pre- and Post-Transplant Patient Care

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will be sharing the latest data on AlloSure® Kidney and its patient-centered digital health solutions at the American Society of Nephrology (ASN) Kidney Week 2022 meeting being held November 3 – 6 in Orlando, Florida.
Read the complete press release on CareDx.com.

Loading